SeaStar Medical Holding Corporation(ICU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ICU SeaStar Medical Holding Corporation

Not Yet Opened 12-20 16:00:00 EST

2.06

+0.02

+0.98%

盘后2.05

-0.01-0.49%

19:55 EST

High2.10	Low2.01	Vol214.48K
Open2.01	D1 Closing2.04	Amplitude4.41%
Mkt Cap9.19M	Tradable Cap9.03M	Total Shares4.46M
T/O442.81K	T/O Rate4.89%	Tradable Shares4.38M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ICU","market":"US","secType":"STK","nameCN":"SeaStar Medical Holding Corporation","latestPrice":2.06,"timestamp":1734728400000,"preClose":2.04,"halted":0,"volume":214480,"hourTrading":{"tag":"盘后","latestPrice":2.05,"preClose":2.06,"latestTime":"19:55 EST","volume":14896,"amount":30683.48,"timestamp":1734742517095},"delay":0,"floatShares":4382215,"shares":4463148,"eps":-10.308776,"marketStatus":"Not Yet Opened","change":0.02,"latestTime":"12-20 16:00:00 EST","open":2.01,"high":2.1,"low":2.01,"amount":442814.378496,"amplitude":0.044118,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-10.308776,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1734944400000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":2.04,"preHourTrading":{"tag":"盘前","latestPrice":2.081,"preClose":2.04,"latestTime":"09:29 EST","volume":7022,"amount":14526.078557,"timestamp":1734704982254},"postHourTrading":{"tag":"盘后","latestPrice":2.05,"preClose":2.06,"latestTime":"19:55 EST","volume":14896,"amount":30683.48,"timestamp":1734742517095},"volumeRatio":0.9333560787092097},"requestUrl":"/m/hq/s/ICU/tweets","defaultTab":"tweets","newsList":[{"id":"2492973448","title":"Aridis Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2492973448","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492973448?lang=en_us&edition=fundamental","pubTime":"2024-12-20 21:00","pubTimestamp":1734699600,"startTime":"0","endTime":"0","summary":"LOS GATOS, Calif., Dec. 20, 2024  -- Aridis Pharmaceuticals, Inc.  , a biopharmaceutical company, today announced a corporate update on recent developments.The Company has substantially reduced its operational cash burn by delaying the expenses associated with SEC filings in favor of business development discussions with potential partners and investors. As a result of voluntary non-compliance, the Company was transitioned to and expects to continue to be listed on the OTC Expert Market until a positive outcome from the business development effort on one or more of its programs.The discussions with potential partners and investors to continue the development of AR-301 resulted in an investment proposal from a globally recognized private investment firm in an amount that the Company believes is sufficient to complete the second and final Phase 3 study and product approval. The Company is working closely with the investment firm to satisfy specific requirements for the closing of investm","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/TdPij3p80iBZC60HHYbkng--~B/aD0zNjE7dz01Mzk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/de744cc0cc25204099101ccc021f87ba","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/TdPij3p80iBZC60HHYbkng--~B/aD0zNjE7dz01Mzk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/de744cc0cc25204099101ccc021f87ba"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aridis-provides-corporate-130000046.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CF","BK4588","BK4093","BNTX","HAP","ICU","BK4551","BK4139","BK4082","BK4548","BK4535","BK4585","ARDS","BK4568"],"gpt_icon":0},{"id":"2492291192","title":"Hansa Biopharma announces positive full results from 15-HMedIdeS-09 Phase 2 study and comparative analysis of imlifidase in patients with Guillain-Barré Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2492291192","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492291192?lang=en_us&edition=fundamental","pubTime":"2024-12-18 06:18","pubTimestamp":1734473880,"startTime":"0","endTime":"0","summary":"LUND, Sweden, Dec. 17, 2024 /PRNewswire/ -- Hansa Biopharma, \"Hansa\" , today announced positive full results from the 15-HMedIdeS-09 single arm Phase 2 study of imlifidase, a first in class IgG cleaving enzyme, in Guillain-Barré Syndrome  and an indirect treatment comparison of the 15-HMedIdeS-09 study data to the International Guillain-Barré Syndrome Outcome Study , a worldwide prospective study by the Inflammatory Neuropathy Consortium on prognosis and biomarkers of GBS.In GBS, IgG is a key driver of inflammatory attacks on peripheral nerves and has been clinically linked to the severity and progression of the disease. Rapid reduction of IgG levels has the potential to benefit GBS patients by depleting pathological IgG antibodies, thereby halting disease progression resulting in faster recovery and less severe disease.1 Improvement in GBS DS is important because it directly affects the clinical outcomes, recovery, and quality of life for patients. Better management of disease severit","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/SHH9HqHTTHVufLIQGN4EBA--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/48dd0b14fd860cf9fb39ebe77b0bce44","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/SHH9HqHTTHVufLIQGN4EBA--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/48dd0b14fd860cf9fb39ebe77b0bce44"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/hansa-biopharma-announces-positive-full-221800038.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hansa-biopharma-announces-positive-full-221800038.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MRC","MG","GBSG","BK4123","IE00B19Z4B17.USD","ICU","IE00B7SZL793.SGD","BK4104","IE00B66KJ199.SGD","IE0031619046.USD","BK4082","HNSBF","BK4139"],"gpt_icon":0},{"id":"2491985226","title":"Annexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched Patient Cohort for the Treatment of Guillain-Barré Syndrome (GBS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2491985226","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491985226?lang=en_us&edition=fundamental","pubTime":"2024-12-16 20:30","pubTimestamp":1734352200,"startTime":"0","endTime":"0","summary":"Real-World Evidence Study Strengthens the Body of Evidence Supporting ANX005 for Treatment of GBS ANX005 Phase 3 Population Was Matched 1:1 on Prespecified Criteria with Patients in International GBS ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/16/2997418/0/en/Annexon-Announces-Positive-Topline-Results-from-Real-World-Evidence-Study-Comparing-ANX005-Treatment-to-Intravenous-Immunoglobulin-IVIg-or-Plasma-Exchange-PE-in-a-Matched-Patient-C.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICU","GBSG","BK4104","BK4139","BK4082","MRC","ANNX"],"gpt_icon":0},{"id":"2490859120","title":"Jefferies Upgrades ICU Medical to Buy From Hold, Price Target is $200","url":"https://stock-news.laohu8.com/highlight/detail?id=2490859120","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490859120?lang=en_us&edition=fundamental","pubTime":"2024-12-11 20:49","pubTimestamp":1733921355,"startTime":"0","endTime":"0","summary":"ICU Medical (ICUI) has an average rating of overweight and mean price target of $188.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ICUI","ICU"],"gpt_icon":0},{"id":"2490785889","title":"SeaStar Medical sees TAM for SCD in five clinical indications of $25B-$35B","url":"https://stock-news.laohu8.com/highlight/detail?id=2490785889","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490785889?lang=en_us&edition=fundamental","pubTime":"2024-12-11 19:35","pubTimestamp":1733916930,"startTime":"0","endTime":"0","summary":"SeaStar Medical (ICU) estimates a U.S. total addressable market for its proprietary, patented Selective Cytopheretic Device in five clinical indica...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/seastar-medical-sees-tam-for-scd-in-five-clinical-indications-of-25b-35b?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/seastar-medical-sees-tam-for-scd-in-five-clinical-indications-of-25b-35b?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SCD","ICU","BK4082"],"gpt_icon":0},{"id":"2490831268","title":"ICU Medical: Buy Rating Affirmed Amid Strong Growth Potential and Strategic Ventures","url":"https://stock-news.laohu8.com/highlight/detail?id=2490831268","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490831268?lang=en_us&edition=fundamental","pubTime":"2024-12-11 18:16","pubTimestamp":1733912183,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Michael Toomey from Jefferies upgraded ICU Medical (ICUI – Research Report) to a Buy, with a price target of $200.0...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/icu-medical-buy-rating-affirmed-amid-strong-growth-potential-and-strategic-ventures?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/icu-medical-buy-rating-affirmed-amid-strong-growth-potential-and-strategic-ventures?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ICUI","ICU"],"gpt_icon":0},{"id":"2489259752","title":"ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2489259752","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489259752?lang=en_us&edition=fundamental","pubTime":"2024-12-06 20:19","pubTimestamp":1733487555,"startTime":"0","endTime":"0","summary":"You may think that with a price-to-sales (or \"P/S\") ratio of 1.6x ICU Medical, Inc. ( NASDAQ:ICUI ) is a stock worth...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-icui/icu-medical/news/icu-medical-incs-nasdaqicui-shares-lagging-the-industry-but-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BGHQF748.EUR","BK4585","QLD","SG9999015978.USD","ICU","LU0012050646.USD","PSQ","IE00BKPKM429.USD","LU0240878834.USD","MNQmain","SG9999015986.USD","IE00B64PRP62.GBP","LU0205194284.USD","BK4082","LU2095319765.USD","QID","SG9999015945.SGD","SG9999015952.SGD","NQmain","NDAQ","SQQQ","TQQQ","ICUI","IE00B3QW5Z07.USD","BK4588","LU2210149790.SGD","LU0106261612.USD","LU0205193047.USD","LU2210150020.SGD","LU0240877869.USD","BK4198","BK4112",".IXIC"],"gpt_icon":1},{"id":"2488196090","title":"SeaStar Medical to Hold Business Update Conference Call on December 11, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2488196090","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488196090?lang=en_us&edition=fundamental","pubTime":"2024-12-04 21:30","pubTimestamp":1733319000,"startTime":"0","endTime":"0","summary":"DENVER, Dec. 04, 2024  -- SeaStar Medical Holding Corporation , a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that management will hold a conference call to discuss business progress and updates.Wednesday, December 11, 4:30 p.m. ET / 1:30 p.m. PT. Participants can pre-register for the conference call here:. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.Those who choose not to pre-register can access the live conference call by dialing the following and requesting the SeaStar Medical call:. The live webcast of the conference call also will be available here. A replay of the call will be available for 48 hours beginning two hours after its completion by dialing 877-344-7529 from within the U.S., 855-669","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/77SCHuX_iFU.xxQG1JdOgw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/33d3e01de9aac4e2dc68a149c9d65f9c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/77SCHuX_iFU.xxQG1JdOgw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/33d3e01de9aac4e2dc68a149c9d65f9c"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/seastar-medical-hold-business-conference-133000270.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","ICUCW","ICU"],"gpt_icon":0},{"id":"2488948640","title":"SeaStar Medical announces activation of Sentara Norfolk General as active site","url":"https://stock-news.laohu8.com/highlight/detail?id=2488948640","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488948640?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:40","pubTimestamp":1733233216,"startTime":"0","endTime":"0","summary":"SeaStar Medical (ICU) announces the activation of Sentara Norfolk General Hospital in Norfolk, Virginia as its thirteenth active site in its NEUTRA...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/seastar-medical-announces-activation-of-sentara-norfolk-general-as-active-site?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/seastar-medical-announces-activation-of-sentara-norfolk-general-as-active-site?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ICU","BK4082"],"gpt_icon":0},{"id":"2488175029","title":"SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult Aki Pivotal Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2488175029","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488175029?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:30","pubTimestamp":1733232602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nTUA66M76B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","ICU"],"gpt_icon":0},{"id":"2488917754","title":"SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2488917754","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488917754?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:30","pubTimestamp":1733232600,"startTime":"0","endTime":"0","summary":"DENVER, Dec.  03, 2024  (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/03/2990640/0/en/SeaStar-Medical-Activates-Sentara-Norfolk-General-Hospital-and-Provides-Enrollment-Update-in-Adult-AKI-Pivotal-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICU","BK4082","SCD"],"gpt_icon":0},{"id":"2488678011","title":"Autolus Therapeutics Announces Publication of Data from the FELIX study of obe-cel in r/r Adult B-ALL Patients in The New England Journal of Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2488678011","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488678011?lang=en_us&edition=fundamental","pubTime":"2024-12-02 20:00","pubTimestamp":1733140800,"startTime":"0","endTime":"0","summary":"High overall response rate: 76.6% of patients in the pivotal cohort achieved CR/Cri following treatment with obe-cel with a median follow-up of 20.3 monthsLow incidence of immune-related toxicity: Gra","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/02/2989661/0/en/Autolus-Therapeutics-Announces-Publication-of-Data-from-the-FELIX-study-of-obe-cel-in-r-r-Adult-B-ALL-Patients-in-The-New-England-Journal-of-Medicine.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","LU1699723380.USD","BK4082","BK4107","BK4132","LU1571399168.USD","LU2355687059.USD","BK4139","OS","UCL","BK4097","LU0985320562.USD","ALL","LENZ","ICU","BK4533"],"gpt_icon":0},{"id":"2486077155","title":"SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2486077155","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486077155?lang=en_us&edition=fundamental","pubTime":"2024-11-26 21:00","pubTimestamp":1732626000,"startTime":"0","endTime":"0","summary":"DENVER, Nov. 26, 2024  -- SeaStar Medical Holding Corporation , a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that management will present a company overview at NobleCon20, Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference, on Wednesday, December 4 at 12:00 p.m. Eastern time . The conference is being held in Boca Raton, Fla.A webcast of the presentation will be available beginning December 5 on the Company website and will be archived for 90 days.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/77SCHuX_iFU.xxQG1JdOgw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/33d3e01de9aac4e2dc68a149c9d65f9c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/77SCHuX_iFU.xxQG1JdOgw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/33d3e01de9aac4e2dc68a149c9d65f9c"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/seastar-medical-present-noble-capital-130000482.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","ICUCW","ICU","NBL"],"gpt_icon":0},{"id":"2485266485","title":"BRIEF-Iss And Glass Lewis Support Seastar Medical's Proposals To Ratify Issuance Of Shares And To Reduce Number Of Authorized Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2485266485","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485266485?lang=en_us&edition=fundamental","pubTime":"2024-11-22 22:20","pubTimestamp":1732285245,"startTime":"0","endTime":"0","summary":"BRIEF-Iss And Glass Lewis Support Seastar Medical's Proposals To Ratify Issuance Of Shares And To Reduce Number Of Authorized SharesNov 22 (Reuters) - SeaStar Medical Holding Corp ICU.O:ISS AND GLASS ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nFWN3MT10H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ICU"],"gpt_icon":0},{"id":"2485408268","title":"Iss and Glass Lewis Support SeaStar Medical's Proposals to Ratify Issuance of Shares and to Reduce Number of Authorized Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2485408268","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485408268?lang=en_us&edition=fundamental","pubTime":"2024-11-22 21:32","pubTimestamp":1732282352,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nFWN3MT10H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","ICU"],"gpt_icon":0},{"id":"2485121539","title":"Maxim Group Reaffirms Their Buy Rating on SeaStar Medical Holding (ICU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2485121539","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485121539?lang=en_us&edition=fundamental","pubTime":"2024-11-21 03:05","pubTimestamp":1732129513,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Anthony Vendetti maintained a Buy rating on SeaStar Medical Holding (ICU – Research Report) yesterday. The company’s shares ope...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-reaffirms-their-buy-rating-on-seastar-medical-holding-icu?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-reaffirms-their-buy-rating-on-seastar-medical-holding-icu?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ICU"],"gpt_icon":0},{"id":"2483376992","title":"SeaStar Medical reaches milestone of 100th QUELIMMUNE commercial device","url":"https://stock-news.laohu8.com/highlight/detail?id=2483376992","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483376992?lang=en_us&edition=fundamental","pubTime":"2024-11-15 21:35","pubTimestamp":1731677717,"startTime":"0","endTime":"0","summary":"SeaStar Medical (ICU) has begun shipping QUELIMMUNE to a third hospital customer. QUELIMMUNE is the Company’s Selective Cytopheretic Device, SCD, f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/seastar-medical-reaches-milestone-of-100th-quelimmune-commercial-device?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/seastar-medical-reaches-milestone-of-100th-quelimmune-commercial-device?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ICU","BK4082"],"gpt_icon":0},{"id":"2483712375","title":"SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer","url":"https://stock-news.laohu8.com/highlight/detail?id=2483712375","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483712375?lang=en_us&edition=fundamental","pubTime":"2024-11-15 21:30","pubTimestamp":1731677400,"startTime":"0","endTime":"0","summary":"DENVER, Nov.  15, 2024  (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/15/2982001/0/en/SeaStar-Medical-Reaches-Milestone-of-100th-QUELIMMUNE-Commercial-Device-as-Shipments-Begin-to-its-Third-Hospital-Customer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCD","ICU","BK4082","HUD"],"gpt_icon":0},{"id":"2483878326","title":"ICU Medical, Inc. (NASDAQ:ICUI) Just Reported And Analysts Have Been Lifting Their Price Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=2483878326","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483878326?lang=en_us&edition=fundamental","pubTime":"2024-11-15 18:44","pubTimestamp":1731667442,"startTime":"0","endTime":"0","summary":"Shareholders might have noticed that ICU Medical, Inc.  filed its third-quarter result this time last week. The early response was not positive, with shares down 3.7% to US$172 in the past week. Revenues of US$589m beat expectations by a respectable 2.2%, although statutory losses per share increased. ICU Medical lost US$1.35, which was 87% more than what the analysts had included in their models. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on ICU Medical after the latest results.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/DGkyMqml3gFWOGvNtEHcnA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/DGkyMqml3gFWOGvNtEHcnA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab"],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/icu-medical-inc-nasdaq-icui-104402651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":[".IXIC","ICU","NDAQ","ICUI"],"gpt_icon":0},{"id":"2483331388","title":"Seastar Medical Faces Distribution Challenges with Self-Marketing of QUELIMMUNE","url":"https://stock-news.laohu8.com/highlight/detail?id=2483331388","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483331388?lang=en_us&edition=fundamental","pubTime":"2024-11-15 14:01","pubTimestamp":1731650510,"startTime":"0","endTime":"0","summary":"Seastar Medical Holding Corporation (ICU) has disclosed a new risk, in the Supply Chain category. Seastar Medical Holding Corporation recently ende...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/seastar-medical-faces-distribution-challenges-with-self-marketing-of-quelimmune?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/seastar-medical-faces-distribution-challenges-with-self-marketing-of-quelimmune?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","ICU"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.seastarmedical.com","stockEarnings":[{"period":"1week","weight":0.0352},{"period":"1month","weight":-0.0419},{"period":"3month","weight":-0.5453},{"period":"6month","weight":-0.7143},{"period":"1year","weight":-0.8157},{"period":"ytd","weight":-0.8139}],"compareEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":0.0011},{"period":"3month","weight":0.0403},{"period":"6month","weight":0.0857},{"period":"1year","weight":0.2506},{"period":"ytd","weight":0.2437}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. SeaStar Medical Holding Corporation is headquartered in Denver, Colorado.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.260345},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.111117},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.122984},{"month":4,"riseRate":0.75,"avgChangeRate":-0.043313},{"month":5,"riseRate":0,"avgChangeRate":-0.248056},{"month":6,"riseRate":0.5,"avgChangeRate":-0.044386},{"month":7,"riseRate":0.75,"avgChangeRate":0.039842},{"month":8,"riseRate":0.25,"avgChangeRate":-0.231767},{"month":9,"riseRate":0.75,"avgChangeRate":-0.027957},{"month":10,"riseRate":0.5,"avgChangeRate":0.472322},{"month":11,"riseRate":0.25,"avgChangeRate":-0.293353},{"month":12,"riseRate":0,"avgChangeRate":-0.086658}],"exchange":"NASDAQ","name":"SeaStar Medical Holding Corporation","nameEN":"SeaStar Medical Holding Corporation"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SeaStar Medical Holding Corporation(ICU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SeaStar Medical Holding Corporation(ICU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SeaStar Medical Holding Corporation,ICU,SeaStar Medical Holding Corporation股票,SeaStar Medical Holding Corporation股票老虎,SeaStar Medical Holding Corporation股票老虎国际,SeaStar Medical Holding Corporation行情,SeaStar Medical Holding Corporation股票行情,SeaStar Medical Holding Corporation股价,SeaStar Medical Holding Corporation股市,SeaStar Medical Holding Corporation股票价格,SeaStar Medical Holding Corporation股票交易,SeaStar Medical Holding Corporation股票购买,SeaStar Medical Holding Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SeaStar Medical Holding Corporation(ICU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SeaStar Medical Holding Corporation(ICU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction